ReviewAnnals of hematology2025

Intrathecal rituximab in pediatric CD20-positive central nervous system limited lymphoproliferative disease: report of two cases and literature review.

Huixia Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.